Authors
Loading...
Case series reveals compound heterozygous mutations in citrullinemia type II, suggesting exome sequencing enhances MADD diagnosis.
Lin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: